Top Drug Delivery Solutions Companies - 2023
ApiJect Systems, Corp: Revolutionizing Prefilled Syringes with Blow-Fill-Seal Technology

Top 10 Drug Delivery Solutions Companies - 2023

As AI and machine learning techniques impact biomedical research, they are providing the new potential to boost drug delivery systems.

AI acts as a robust tool to establish structure-function relationships between formulation parameters and release kinetics and helps tune a drug delivery system for optimal performance. For instance, a cascade computer model is designed to predict drug diffusivity from different mucoadhesive formulations. AI, in this regard, can aid in drug discovery, repurposing, side effect prediction, and clinical trials. It also assists in decision-making to determine the right therapy for patients, including personalized medicines. This makes drug development procedures cost-effective, faster, and more productive.

With many other momentous innovations, the drug delivery market is expected to grow at a CAGR of 5.9 percent by 2026 to reach $2206.5 billion.

To put the spotlight on other key developments in the industry, MedTech Outlook illustrates how drug delivery solutions are being utilized to drive the next patient care evolution. This edition also features thought leadership articles from subject matter experts. Some of the exclusive insights are authored by Antoni Chan, MBChB, PhD, FRCP, Clinical Lead in Rheumatology, Royal Berkshire NHS Foundation Trust, UK; Singithi Chandrasiri, Deputy Chief Medical Officer and Group Director, Academic and Medical Services at Epworth.

In this edition of MedTech Outlook, we also bring you the stories of top drug delivery solution providers. In the list, ApiJect Systems stands out with the idea that more injectable medications and vaccines should be efficiently filled and given to patients in single-dose prefilled injection devices using blow-fill-seal (BFS) technology. Equally commendable is Vivera Pharmaceuticals, which has global exclusivity to license the patented and patent pending TABMELT sublingual drug delivery system for pharmaceutical use.

Through the following pages, we aim to shine a light on the innovative trends and latest developments in the drug delivery space. We would like to know your thoughts.

    Top Drug Delivery Solutions Companies

    ApiJect Systems, Corp
    ApiJect combines the competencies of aseptic blow-fill-seal (BFS) drug packaging technology with plastic injection molded components to create single-dose, high-quality, prefilled drug delivery systems, subject to FDA approval. ApiJect is driven to improve how sterile liquid medicines and vaccines are fill-finished to help pharmaceutical companies design drug delivery systems cost-effectively and at scale, with a goal to help make injectable medicines and vaccines safe and accessible for everyone.
    Vivera Pharmaceuticals
    Vivera is an innovative biopharma and medical technologies company dedicated to revolutionizing drug delivery. The company has global exclusivity to license the patented and patent-pending TABMELT sublingual drug delivery system for pharmaceutical use and holds its own issued patents on ZICOH, a smart, dose-controlled electronic medical device, and MDZone, a portable telemedicine station.
    Avanos Medical
    Avanos Medical is a global medical device company committed to creating the next generation of innovative healthcare solutions to help patients get back to the things that matter. Avanos Medical develop, manufacture and market recognized brands in more than 90 countries.
    Clearside Biomedical
    Clearside Biomedical is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). Clearside is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector and strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations.
    CVRx
    CVRx is a commercial stage, public medical devices company which has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. CVRx’s Barostim is a breakthrough technology that stimulates the body’s natural baroreflex to treat heart failure.
    Delcath Systems
    Delcath Systems is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers.
    Neosinus Health
    Neosinus Health is a drug development platform company that has commercialized a fully integrated Platform for optimizing drug delivery and health outcomes. The core platform is designed to optimize the delivery of medications to essential drug pathways and overcome physiological barriers that currently impede high potential drugs.
    Nura Clinics
    Nura Clinics specializes in precision pain management therapies and procedures to help those who struggle with chronic pain get their life back. Nura is nationally recognized as a center of excellence for implantable pain control and one of the leading pain clinics in the U.S.
    PassPort Technologies
    PassPort Technologies is focused on the development of therapeutics using advanced drug delivery systems. With strong technical knowledge and decades of experience in both pharmaceutical sciences and engineering, the PassPort Technologies team possesses the necessary expertise in transdermal formulation and medical device development that PassPort® system requires.
    Recipharm
    Recipharm is a leading global pharmaceutical Contract Development and Manufacturing Organisation (CDMO) that provides pharmaceutical companies around the world with tailor-made development and manufacturing services, including a wide variety of drug dosage forms, and inhalation products and devices.

Drug Delivery Solutions Info

Q1
What Do Top Drug Delivery Solutions Do?
Top drug delivery solutions comprise devices, platforms, formulations, and patient support technologies used to guide drugs to the desired location, at the intended dosage, and at the required frequency. Real-world applications span injections, inhalation systems, transdermal patches, implantable devices, connected dispensers, and patient-adherence enabling packaging. For life science organizations, care providers, and health systems, the category sits between designing the therapy and applying it in practice. An optimal drug delivery solution needs to ensure product stability, ensure patient safety, and fit into clinical workflow without excessive complexity.
Q2
Why Do Drug Delivery Solutions Matter Now?
The need for top drug delivery solutions is rising as more therapies are developed that go beyond simply oral delivery, including biologics, specialty medicines, chronic disease regimens and home-based care models that may have dose accuracy and compliance challenges. Pharmas and hospitals are worried about drug shortages and supply chain pressures and expect enhanced traceability. Patient convenience and home care initiatives, coupled with the need to deliver beyond the molecule's capability, are driving demand. Usability, safety mechanisms and full life cycle support are just as competitive now as the actual hardware design of drug delivery solutions.
Q3
How Should Healthcare and Life Sciences Decision-Makers Evaluate Providers?
Evaluation should begin with the therapy, patient setting and risk profile. A delivery platform for a pediatric inhaled therapy has different requirements than an autoinjector for a biologic or a secured dispenser for controlled medication. Decision-makers should review regulatory readiness, human factors testing, manufacturing quality, dose accuracy, packaging compatibility and post-market support. Integration also matters. A provider may have a strong device concept but weak documentation, limited production scale or gaps in clinical training. The best drug delivery solutions providers make those limits visible early.
Q4
What Value Do Top Drug Delivery Solutions Create for Patients and Care Teams?
The most value can be seen from top drug delivery solutions that smooth the path between prescription and delivery. Value for patients could range from improved adherence to fewer painful shots to clearer instructions or greater comfort with therapy at home. Care teams may realize fewer nurse callbacks, better adherence reports, and fewer avoidable complications due to misuse. Buyers within pharma and medtech would see value in delivery configurations that enable product differentiation, reach additional therapies and eliminate waste. However, it's the small details that are often most valuable: grip, dose confirmation, training resources and refill processes.
Q5
How Are Technology and Expertise Changing Drug Delivery Solutions?
Technology is adding extra complexity, but in the end, human use is the real test. Devices like connected injectors, smart dispensers and digital reminders can improve compliance, but must be usable when the patient is weary, worried and possibly administering multiple drugs. Meanwhile, materials science, microfluidics, aerosol engineering and wearable delivery systems allow us to bring medicine outside the hospital or surgery. Specialized knowledge is critical, as each choice involves compromise: viscosity, storage, administration time, sterile handling and patient finger-dexterity all influence whether or not a product succeeds in the real world outside of a clinical trial.
Q6
What Should Decision-Makers Prioritize When Comparing Drug Delivery Solutions Providers?
Decision-makers comparing Top Drug Delivery Solutions should prioritize evidence, fit and execution discipline. A provider should be able to explain how its platform performs across dose accuracy, patient handling, manufacturability, regulatory documentation and training requirements. Cost matters, but a low-cost design can become expensive if it creates refill problems, adverse-event risk or delayed scale-up. The strongest comparisons look past the device brochure and examine the full path from therapy requirements to patient use. Top Drug Delivery Solutions should make medication delivery safer, clearer and more dependable in routine care.